eTheRNA immunotherapies conference attendance for May- June 2021

eTheRNA immunotherapies NV (‘eTheRNA’), a clinical-stage company developing LNP-formulated mRNA immunotherapies as off-the shelf products for the treatment of cancer and infectious diseases, will be attending the following conferences during May and June:

Read more…

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...